- PodcastEpisode 57Duration 34:07
Harlan reports on a unprecedented recall of ventilators and CPAP machines; Howie discusses a new approach to tackling the issue of antimicrobial resistance. And they’re joined by Dr. Nancy Brown, dean of the Yale School of Medicine, to discuss her career path and her investments in developing talent.
- PodcastEpisode 56Duration 36:45
Harlan provides updates on R.S.V., flu, and COVID-19; Howie considers the growing use of hallucinogens for treatment of severe depression. And they are joined by Dr. Vineet Arora, dean of medical education at the University of Chicago, to discuss the future of medical Twitter and how medical education is changing in the wake of the pandemic.
- PodcastEpisode 55Duration 33:11
Harlan reports on three negative—but striking—trials presented at the American Heart Association’s annual meeting; Howie reflects on the victories for health in Tuesday’s election. And they’re joined by Dr. Marcella Nunez-Smith, a Yale internist and nationally known expert on healthcare equity, to discuss her service in the Biden administration and the need for a broad approach to tackling racism in healthcare and systemic inequities in health.
- PodcastEpisode 54Duration 33:29
Harlan describes a revealing new study on the long-term impacts of COVID; Howie reflects on the escalating costs of health insurance. And they are joined by Dr. Lisa Leffert, Yale’s chief of anesthesiology, to discuss her unusual career path, disparities in maternal mortality, and her approach to tackling the gender pay gap in the field.
- PodcastEpisode 53Duration 34:54
Howie and Harlan are joined by physician, sociologist, and thinker Nicholas Christakis to talk about how humans have evolved to form powerful connections. Howie provides updates on concussions among high school athletes and the use of Ivermectin for COVID, and Harlan remembers Dr. Barry Zaret, an important figure in cardiology at Yale and beyond.
- PodcastEpisode 52Duration 37:44
Harlan reports on a new study testing the effectiveness of the OCD drug fluvoxamine in treating COVID; Howie reflects on the potential of continuous glucose monitoring for people with diabetes. And they’re joined by Dr. Utibe Essien of the University of Pittsburgh to discuss the barriers preventing people of color from getting innovative new treatments and medications.
- PodcastEpisode 51Duration 33:06
Howie and Harlan check in on new research and health issues in the news, including studies on colonoscopies and the timing of hypertension medication, the state of the monkey pox and polio outbreaks, and the wave of legislation restricting treatment of trans youth.
- PodcastEpisode 50Duration 35:13
Howie and Harlan look at the plunging cost of sequencing an individual genome, and the problem of concussions among athletes at all levels. And they’re joined by Dr. Ania Jastreboff, a Yale obesity specialist, to discuss the dramatic results from a new class of drugs that target the brain’s system for regulating body fat.
- PodcastEpisode 49Duration 31:13
Harlan discusses the problem of “financial toxicity”—how medical bills can wreak havoc in vulnerable patients’ lives. Howie reflects on the protests in Iran and the precariousness of the freedoms we enjoy in the United States. And they are joined by Ingrid Nembhard of the University of Pennsylvania to discuss her work on the organizational factors that shape patient care.
- PodcastEpisode 48Duration 30:53
Howie and Harlan react to President Joe Biden’s declaration that the pandemic is over. Then they’re joined by Jonathan Rothberg, a Yale-trained scientist who has created new methods for sequencing DNA and founded a series of successful biotech companies.
Disclosure: Harlan Krumholz is a consultant to Tesseract, a portfolio company of 4 Catalyzer, which was founded by Jonathan Rothberg.